Safety and Performance

2

Review clinical trials related to Safety and Performance. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Post-marketing Clinical Monitoring of Safety and Performance of Breast Tissue Expander for Breast Reconstruction

The study investigates the safety and performance of Silimed® brand breast tissue expander in women born with indication for breast reconstruction. The safety of the breast tissue expander will be evaluated by estimating known and unexpected adverse event rates through patient reports of adverse events after implantation. The performance of using Silimed® brand breast tissue expander will be evaluated by evaluating the assessment of tissue quality and satisfaction by the evaluating physician after implantation.

Participants needed: 152
Trial details
Age: 18+Biological sex: FemaleType: ObservationalSponsor: Silimed Industria de Implantes LtdaUpdated: Mar 13, 2026Locations: 3
Eligibility criteria

provide written informed consent [+5]

breast augmentation without reconstruction in at least one breast; [+12]

Status: Recruiting

An Analysis of Adverse Events and Satisfaction Outcomes of Women Who Underwent Primary and Secondary Breast Augmentation Using Silimed® Breast Implants With Smooth Surface

The study investigates the safety and performance of Silimed® brand smooth surface breast implants in women born with indication for primary and secondary (revision) augmentation to be followed up for 10 years. The safety of the smooth-surfaced Silimed® implant will be evaluated by estimating known and unexpected short-term and long-term risk/adverse event rates through patient reports of adverse events after implantation. The performance of using Silimed® brand smooth surface breast implants will be evaluated by evaluating satisfaction and quality of life after implantation.

Participants needed: 384
Trial details
Age: 18+Biological sex: FemaleType: ObservationalSponsor: Silimed Industria de Implantes LtdaUpdated: Mar 16, 2026Locations: 1
Eligibility criteria

Provide written informed consent [+5]

Replacement of breast implants due to a complication [+13]